 9 Meters Biopharma Inc NASDAQ: NMTR has collaborated with the European Biomedical Research Institute of Salerno, Italy EBRIS to study larazotide for multisystem inflammatory syndrome in children MIS-C. Larazotide is a novel first-in-class tight junction regulator that the Company currently has in Phase 3 trial for adults with celiac disease. 